This cancer therapy uses the body's immunity to fight the disease

In HITV, dendritic cells are harvested from the patient and cultured in a laboratory before they are reintroduced back into the patient's body.

Malaysia will soon have its own Hasumi Immunotherapy centre for the treatment of cancer — the first of its kind outside of Japan.

The Mahameru International Medical Centre (MIMC) in Bangsar, Kuala Lumpur, has just been granted the exclusive global licensing rights to expand the use of the Hasumi Immuno-Therapeutic Vaccine (HITV), which is used in the treatment of stage four cancer.